Gene Expression Analysis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2024 - 2029)

The Gene Expression Analysis Market is segmented by Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Microarrays, and Others), Product (Instruments, Reagents and Consumables, and Services), End-user (Drug Discovery, Diagnostic Laboratories, and Academic Research Centers), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report offers the value (in USD million) for the above segments.

Gene Expression Analysis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2024 - 2029)

Gene Expression Analysis Industry Overview

The market studied is moderately consolidated, owing to the presence of many small and large market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some market players are QIAGEN, Quest Diagnostics Incorporated, F. Hoffmann-La Roche Ltd, Illumina, Inc., Novogene Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, Promega Corporation, and Luminex Corporation. Regional and service portfolio expansions and mergers and acquisitions are key strategic undertakings adopted by these players.

Gene Expression Analysis Market Leaders

  1. Quest Diagnostics Incorporated

  2. Illumina, Inc.

  3. PerkinElmer Inc.

  4. Agilent Technologies

  5. Promega Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Picture2.png

Global Gene Expression Analysis Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?